Compare AVNS & IGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVNS | IGD |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 521.7M | 463.0M |
| IPO Year | 2014 | N/A |
| Metric | AVNS | IGD |
|---|---|---|
| Price | $13.88 | $5.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 545.6K | 292.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.15% |
| EPS Growth | ★ 81.59 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $701,200,000.00 | N/A |
| Revenue This Year | $3.28 | N/A |
| Revenue Next Year | $4.23 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.95 | N/A |
| 52 Week Low | $9.30 | $5.01 |
| 52 Week High | $15.68 | $6.04 |
| Indicator | AVNS | IGD |
|---|---|---|
| Relative Strength Index (RSI) | 48.08 | 58.39 |
| Support Level | $10.94 | $5.63 |
| Resistance Level | $15.68 | $5.98 |
| Average True Range (ATR) | 0.57 | 0.05 |
| MACD | -0.21 | 0.00 |
| Stochastic Oscillator | 18.39 | 67.39 |
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.
Voya Global Equity Dividend and Premium Opportunity Fund are a United States-based diversified, closed-end Fund. The primary objective of the Fund is to seek to provide investors with a high level of income from a portfolio of common stocks with historically attractive dividend yields and premiums from call option writing. The secondary investment objective of the company is capital appreciation. Under normal market conditions, the Fund will invest at least 80% of its managed assets in a portfolio of common stocks of dividend-paying companies located throughout the world.